Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • LRRK2 Drug Trial Shares Promising Results, Company to Begin Second Study

    LRRK2 Drug Trial Shares Promising Results, Company to Begin Second Study

    Denali Therapeutics announced its first-in-human LRRK2 inhibitor is safe and lowers LRRK2 protein activity in humans' body cells, meaningful milestones for this potentially disease-modifying…
    Learn more Save for later
  • Protein Levels Linked to Parkinson's Gait Difficulty and Cognitive Problems

    Protein Levels Linked to Parkinson's Gait Difficulty and Cognitive Problems

    Michael J. Fox Foundation-sponsored study links lower spinal fluid levels of alpha-synuclein and beta-amyloid to gait and cognitive problems, respectively.
    Learn more Save for later
  • High-Intensity Treadmill Exercise May Slow Parkinson's Progression

    High-Intensity Treadmill Exercise May Slow Parkinson's Progression

    A new phase II study adds to the growing body of evidence on the effects of exercise for people with Parkinson's.
    Learn more Save for later
  • New Deep Brain Stimulation (DBS) System Approved for Parkinson's

    New Deep Brain Stimulation (DBS) System Approved for Parkinson's

    MJFF chats with Svjetlana Miocinovic, MD, PhD, assistant professor of neurology at Emory University about DBS and the new system.
    Learn more Save for later
  • Record-pace Recruitment for STEADY-PD III Lays Foundation for Other Investigations

    Record-pace Recruitment for STEADY-PD III Lays Foundation for Other Investigations

    A comprehensive recruitment strategy may help speed urgently needed Parkinson’s therapies
    Learn more Save for later
  • Closer to a Cure: Download Our 2017 Research Year in Review

    Closer to a Cure: Download Our 2017 Research Year in Review

    Read highlights from our 2017 Research Year in Review and download the full report for details on the year's critical programs, initiatives and collaborations that brought us closer to a cure.
    Learn more Save for later
  • Inhaled Levodopa Resubmitted to FDA for Review

    Inhaled Levodopa Resubmitted to FDA for Review

    Acorda expects to hear within 74 days whether their inhaled levodopa submission is complete and will be reviewed by the FDA.
    Learn more Save for later
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.